ClinicalTrials.gov record
Completed Early Phase 1 Interventional

Preventing Speech and Language Disorders in Children With Classic Galactosemia

ClinicalTrials.gov ID: NCT03838016

Public ClinicalTrials.gov record NCT03838016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 1:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Babble Boot Camp: Preventing Speech and Language Disorders in Children With Classic Galactosemia

Study identification

NCT ID
NCT03838016
Recruitment status
Completed
Study type
Interventional
Phase
Early Phase 1
Lead sponsor
Arizona State University
Other
Enrollment
285 participants

Conditions and interventions

Interventions

  • Babble Boot Camp Behavioral

Behavioral

Eligibility (public fields only)

Age range
2 Months to 54 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2019
Primary completion
May 30, 2025
Completion
Aug 30, 2025
Last update posted
Jan 22, 2026

2019 – 2025

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Arizona State University Tempe Arizona 85287

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03838016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03838016 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →